ULBI
ULTRALIFE CORP
$6.58
+1.23%
$109.6M
No data for this timeframe.
Vol
Market Cap$109.6M
Cap SizeMicro Cap
Inst. Holders23 funds
Inst. Value$16.8M
Inst. Activity1 buys / 3 sells
Insider Activity8B / 0S
Insider Net $$1.9M
SEC Reports7
Press Releases2
Exchange Nasdaq·Sector Miscellaneous Electrical Machinery, Equipment & Supplies·Inc. DE·CIK 0000875657·Prev Close $6.50
Recent Activity
Jun 2, 2026
SEC
Ultralife Corp filed a DEFA14A (additional definitive proxy soliciting materials) on June 2, 2026. The filing is a place
DEFA14A — Impact 2/10
May 26, 2026
Insider
WHITMORE BRADFORD T bought 67,302 shares
Director @ $6.81 ($458.6K)
May 22, 2026
Insider
WHITMORE BRADFORD T bought 8,700 shares
Director @ $6.33 ($55.1K)
May 21, 2026
Insider
WHITMORE BRADFORD T bought 32,876 shares
Director @ $6.13 ($201.7K)
May 8, 2026
SEC
Ultralife reported Q1 2026 revenue of $47.4M (-6.5% YoY) and GAAP EPS of ($0.03), swinging from $0.11 profit in the prio
8-K — Impact 7/10
May 8, 2026
SEC
Ultralife reported a weak Q1 2026 with revenue down 6.5% YoY to $47.4M and a GAAP net loss of ($0.03)/share vs $0.11 pro
PRESS-RELEASE — Impact 7/10
Inst.
Russell Investments Group, Ltd. — ADD
81,791 shares ($533.3K)
Inst.
MARSHALL WACE, LLP — TRIM
11,078 shares ($72.2K)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 15, 2024 | Benchmark | REITERATE | Buy → Buy |
| Jun 27, 2024 | Benchmark | MAINTAIN | Buy → Buy |
| Mar 5, 2024 | Benchmark | MAINTAIN | Buy → Buy |
| Aug 8, 2023 | Benchmark | REITERATE | Buy → Buy |
| Mar 26, 2021 | Benchmark | INITIATE | Buy |
Latest Reports
NEUTRAL
DEFA14A
2/10
Ultralife Corp filed a DEFA14A (additional definitive proxy soliciting materials) on June 2, 2026. The filing is a place
Jun 2, 2026
BEARISH
8-K
7/10
Ultralife reported Q1 2026 revenue of $47.4M (-6.5% YoY) and GAAP EPS of ($0.03), swinging from $0.11 profit in the prio
May 8, 2026
MIXED
Press
6/10
Ultralife Corporation reported Q4 2025 revenue growth of 10.6% to $48.5 million, driven by strong performance in Battery
Mar 10, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| DIMENSIONAL FUND ADVISORS LP | $6.5M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.0M | — |
| RENAISSANCE TECHNOLOGIES LLC | $1.3M | — |
| Connor, Clark & Lunn | $1.0M | — |
| BlackRock, Inc. | $953.7K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 26, 2026 | WHITMORE BRADFORD | BUY | $458.6K |
| May 22, 2026 | WHITMORE BRADFORD | BUY | $55.1K |
| May 21, 2026 | WHITMORE BRADFORD | BUY | $201.7K |
| May 18, 2026 | Manna Michael | BUY | $12.9K |
| Mar 16, 2026 | WHITMORE BRADFORD | BUY | $359.1K |
23 institutional holders with $16.8M total value (2,583,300 shares) as of 2026-Q1. Top holders: DIMENSIONAL, VANGUARD, RENAISSANCE. Net selling activity: 3 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | DIMENSIONAL FUND ADVISORS LP | 994,846 | $6.5M | 38.5% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 457,837 | $3.0M | 17.7% | — |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 198,090 | $1.3M | 7.7% | — |
| 4 | Connor, Clark & Lunn Investment Management Ltd. | 155,021 | $1.0M | 6.0% | — |
| 5 | BlackRock, Inc. | 146,273 | $953.7K | 5.7% | — |
| 6 | RAYMOND JAMES FINANCIAL INC | 139,333 | $908.5K | 5.4% | ADD +44.9% |
| 7 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 126,753 | $826.4K | 4.9% | TRIM -37.7% |
| 8 | Russell Investments Group, Ltd. | 81,791 | $533.3K | 3.2% | ADD +66.9% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 63,066 | $411.2K | 2.4% | — |
| 10 | TWO SIGMA INVESTMENTS, LP | 62,225 | $405.7K | 2.4% | ADD +41.2% |
| 11 | STATE STREET CORP | 42,820 | $279.2K | 1.7% | TRIM -70.3% |
| 12 | CITADEL ADVISORS LLC | 41,301 | $269.3K | 1.6% | ADD +78.9% |
| 13 | AMERIPRISE FINANCIAL INC | 36,150 | $235.7K | 1.4% | — |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,502 | $107.6K | 0.6% | — |
| 15 | MARSHALL WACE, LLP | 11,078 | $72.2K | 0.4% | TRIM -67.5% |
| 16 | MORGAN STANLEY | 5,704 | $37.2K | 0.2% | TRIM -52.9% |
| 17 | Vanguard Global Advisers, LLC | 2,046 | $13.3K | 0.1% | — |
| 18 | ROYAL BANK OF CANADA | 1,332 | $9.0K | 0.1% | DOUBLED +1035.3% |
| 19 | RHUMBLINE ADVISERS | 604 | $3.9K | 0.0% | NEAR_EXIT -94.1% |
| 20 | FMR LLC | 266 | $1.7K | 0.0% | TRIM -25.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | ADD | 48,997 | 81,791 | +66.9% | $533.3K | 2026-Q1 |
| MARSHALL WACE, LLP | TRIM | 34,049 | 11,078 | -67.5% | $72.2K | 2026-Q1 |
| FMR LLC | TRIM | 358 | 266 | -25.7% | $1.7K | 2026-Q1 |
| CWM, LLC | TRIM | 31 | 23 | -25.8% | $150.00 | 2026-Q1 |
| CWM, LLC | TRIM | 59 | 31 | -47.5% | — | 2025-Q4 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 219,018 | 136,461 | -37.7% | $780.6K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 40,645 | 57,387 | +41.2% | $328.3K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 13,351 | 5,190 | -61.1% | $29.7K | 2025-Q4 |
| FMR LLC | TRIM | 1,020 | 358 | -64.9% | $2.0K | 2025-Q4 |
| CWM, LLC | TRIM | 233 | 59 | -74.7% | — | 2025-Q3 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 70,476 | 219,018 | +210.8% | $1.5M | 2025-Q3 |
| CITADEL ADVISORS LLC | ADD | 45,226 | 80,921 | +78.9% | $551.9K | 2025-Q3 |
| Walleye Capital LLC | DOUBLED | 31,102 | 63,707 | +104.8% | $434.5K | 2025-Q3 |
| Russell Investments Group, Ltd. | DOUBLED | 1,027 | 48,997 | +4670.9% | $334.2K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 17,300 | 40,645 | +134.9% | $277.2K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 9,541 | 13,351 | +39.9% | $91.1K | 2025-Q3 |
| UBS Group AG | TRIM | 7,222 | 4,572 | -36.7% | $31.2K | 2025-Q3 |
| BARCLAYS PLC | DOUBLED | 2 | 1,582 | +79000.0% | $10.8K | 2025-Q3 |
| BARCLAYS PLC | NEAR_EXIT | 10,211 | 2 | -100.0% | — | 2025-Q2 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 12,265 | 70,476 | +474.6% | $632.9K | 2025-Q2 |
| STATE STREET CORP | TRIM | 126,591 | 37,620 | -70.3% | $337.8K | 2025-Q2 |
| Walleye Capital LLC | DOUBLED | 13,688 | 31,102 | +127.2% | $279.3K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 36,336 | 17,300 | -52.4% | $155.4K | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 40,434 | 7,222 | -82.1% | $64.9K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | TRIM | 5,891 | 2,018 | -65.7% | $18.1K | 2025-Q2 |
2 unique insiders with 8 transactions. Net insider value: $1.9M ($1.9M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 26, 2026 | WHITMORE BRADFORD T | Director | BUY | 67,302 | $6.81 | $458.6K |
| May 22, 2026 | WHITMORE BRADFORD T | Director | BUY | 8,700 | $6.33 | $55.1K |
| May 21, 2026 | WHITMORE BRADFORD T | Director | BUY | 32,876 | $6.13 | $201.7K |
| May 18, 2026 | Manna Michael Edward | President and CEO | BUY | 2,000 | $6.47 | $12.9K |
| Mar 16, 2026 | WHITMORE BRADFORD T | Director | BUY | 53,131 | $6.76 | $359.1K |
| Mar 13, 2026 | WHITMORE BRADFORD T | Director | BUY | 100,640 | $6.32 | $636.5K |
| Mar 12, 2026 | Manna Michael Edward | President and CEO | BUY | 1,800 | $6.01 | $10.8K |
| Mar 12, 2026 | WHITMORE BRADFORD T | Director | BUY | 33,741 | $5.97 | $201.3K |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 0 mixed, 4 neutral. Avg impact: 4.4/10.
NEUTRAL
DEFA14A
2/10
Ultralife Corp filed a DEFA14A (additional definitive proxy soliciting materials) on June 2, 2026. T
Jun 2, 2026
BEARISH
8-K
7/10
Ultralife reported Q1 2026 revenue of $47.4M (-6.5% YoY) and GAAP EPS of ($0.03), swinging from $0.1
May 8, 2026
BEARISH
PRESS-RELEASE
7/10
Ultralife reported a weak Q1 2026 with revenue down 6.5% YoY to $47.4M and a GAAP net loss of ($0.03
May 8, 2026
NEUTRAL
PRESS-RELEASE
2/10
Ultralife Corporation announced it will report Q1 2026 results on May 8, 2026, and host a conference
May 1, 2026
NEUTRAL
10-K/A
2/10
Ultralife filed Amendment No. 1 to its 2025 Form 10-K solely to add Part III information (directors,
Apr 29, 2026
BULLISH
CLUSTER
7/10
Four open-market share purchases by Ultralife Corp insiders in the past week, including three by Dir
Mar 16, 2026
NEUTRAL
8-K
4/10
Analysis based on filing metadata only — document content was unavailable. The filing includes Items
Mar 10, 2026
Historical analyst distribution (last covering-analyst action Nov 2024): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
2 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 15, 2024 | Benchmark | REITERATE | Buy | Buy |
| Jun 27, 2024 | Benchmark | MAINTAIN | Buy | Buy |
| Mar 5, 2024 | Benchmark | MAINTAIN | Buy | Buy |
| Aug 8, 2023 | Benchmark | REITERATE | Buy | Buy |
| Mar 26, 2021 | Benchmark | INITIATE | — | Buy |
| May 2, 2013 | Ardour Capital | DOWNGRADE | Hold | Reduce |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Dec 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Nov 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Oct 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 8, 2026
earnings
Ultralife Corporation Reports First Quarter Results
<p align="justify">NEWARK, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quar
May 8, 2026
earnings_calendar
ULBI Q1 2026 Earnings Scheduled — 2026-05-08
May 7, 2026
earnings_calendar
ULBI Q1 2026 Earnings Scheduled — 2026-05-07
May 1, 2026
earnings
Ultralife Corporation to Report First Quarter Results on May 8, 2026
<p align="justify">NEWARK, N.Y., May 01, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the
Apr 23, 2026
earnings_calendar
ULBI Q1 2026 Earnings Scheduled — 2026-04-23
Mar 10, 2026
earnings
Ultralife Corporation Reports Fourth Quarter Results
<p align="justify">NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth qu
Mar 10, 2026
earnings_calendar
ULBI Q4 2025 Earnings Scheduled — 2026-03-10
Mar 9, 2026
earnings_calendar
ULBI Q4 2025 Earnings Scheduled — 2026-03-09
Mar 5, 2026
earnings
Ultralife Corporation to Report Fourth Quarter Results on March 10, 2026
<p align="justify">NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for